Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol
暂无分享,去创建一个
P. Tugwell | D. Rice | D. Beaton | B. Hutton | L. Thabane | B. Shea | L. Maxwell | K. Corace | R. D. de Souza | A. Worster | Z. Samaan | B. Dennis | M. C. Samaan | D. Marsh | S. Sanger | L. Rieb | N. Sanger | Hamnah Shahid | Jacqueline Hudson | Rand Teed
[1] M. Farrell,et al. Maudsley Addiction Profile , 2019 .
[2] Evan Wood,et al. Management of opioid use disorders: a national clinical practice guideline , 2018, Canadian Medical Association Journal.
[3] G. Guyatt,et al. The authors respond to “Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain” , 2017, Canadian Medical Association Journal.
[4] M. Schuckit. Treatment of Opioid-Use Disorders. , 2016, The New England journal of medicine.
[5] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.
[6] Pavel S. Roshanov,et al. Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria , 2015, Trials.
[7] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.
[8] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[9] L. Møller,et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. , 2012, Addiction.
[10] J. Kantelip,et al. Interindividual Variability of Methadone Response , 2008, Molecular Diagnosis & Therapy.
[11] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[12] G. Guyatt,et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.
[13] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[14] R. Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.
[15] J. Rehm,et al. Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study) , 2005, Journal of Urban Health.
[16] G. Bertschy. Methadone maintenance treatment: An update , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[17] R P Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.
[18] M. Farrell,et al. The Maudsley addiction profile: a brief instrument for treatment outcome research. Development and user manual. , 1998 .
[19] D. Metzger,et al. The Fifth Edition of the Addiction Severity Index. , 1992, Journal of substance abuse treatment.